Stockscreener 앱 받기
0.61
0.00%
0.00
시간 외 거래:
.61
전일 마감가:
$0.61
열려 있는:
$0.619
하루 거래량:
10,498
Relative Volume:
0.15
시가총액:
$7.81M
수익:
$2.48M
순이익/손실:
$-12.16M
주가수익비율:
-0.5969
EPS:
-1.0219
순현금흐름:
$-10.35M
1주 성능:
+3.04%
1개월 성능:
-1.61%
6개월 성능:
-75.75%
1년 성능:
-80.25%
1일 변동 폭
$0.5901
$0.632
1주일 범위
$0.5835
$0.639
52주 변동 폭
$0.495
$4.98
Collplant Biotechnologies Ltd Stock (CLGN) Company Profile
Compare CLGN vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLGN
Collplant Biotechnologies Ltd
|
0.61 | 7.81M | 2.48M | -12.16M | -10.35M | -1.0219 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-02-17 | 개시 | Alliance Global Partners | Buy |
Collplant Biotechnologies Ltd 주식(CLGN)의 최신 뉴스
CollPlant (CLGN) director Alisa Lask details option and RSU holdings - Stock Titan
CollPlant Biotechnologies (CLGN) director reports options and RSUs on Form 3 - Stock Titan
CollPlant Biotechnologies (CLGN) director details option and RSU stake - Stock Titan
CollPlant (CLGN) VP reports 25,000 RSUs with 4-year vesting - Stock Titan
CollPlant (NASDAQ: CLGN) VP Legal details options and RSU awards - Stock Titan
CollPlant (CLGN) VP details option and restricted share unit holdings - Stock Titan
CollPlant (NASDAQ: CLGN) VP discloses options, RSUs and shares in Form 3 - Stock Titan
CollPlant (CLGN) VP details options and RSUs stake - Stock Titan
CollPlant Biotechnologies (NASDAQ: CLGN) deputy CEO details option and RSU stakes - Stock Titan
CollPlant Biotechnologies Launches Redesigned Corporate Website - Finviz
CollPlant Biotechnologies Launches Redesigned Corporate Website - Benzinga
Reviewing CG Oncology (NASDAQ:CGON) and CollPlant Biotechnologies (NASDAQ:CLGN) - Defense World
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FULL YEAR 2025 FINANCIAL RESULTS - Finviz
CLGN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler - Intellectia AI
CollPlant secures Korean patent for dermal filler technology - Investing.com Australia
Collplant Biotechnologies Announces Korean Patent Allowance Secured for Its Photocurable Dermal Filler - marketscreener.com
CollPlant (CLGN) Receives Korean Patent for Dermal Filler Techno - GuruFocus
CollPlant Secures Korean Patent Allowance for Photocurable Dermal Filler Platform - TipRanks
CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler - Revista ADVFN
CollPlant launches BioFlex bioink kit for 3D bioprinting By Investing.com - Investing.com India
CollPlant Launches BioFlex rhCollagen Bioink Kit to Advance 3D Bioprinting - The Globe and Mail
CollPlant to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference - Intellectia AI
BioFlex launch expands CollPlant (NASDAQ: CLGN) 3D bioprinting portfolio - Stock Titan
CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex - Barchart.com
What’s the outlook for CollPlant Biotechnologies Ltd.’s sectorRate Hike & High Win Rate Trade Alerts - mfd.ru
CollPlant Moves to Capture GLP-1-Driven Aesthetic Market With Photocurable rhCollagen Filler - TipRanks
CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments - marketscreener.com
New rhCollagen filler targets faces thinned by GLP-1 weight loss - Stock Titan
What is CollPlant Biotechnologies Ltd. s debt to equity ratioJuly 2025 Sentiment & Weekly High Conviction Ideas - mfd.ru
A | Does CollPlant Biotechnologies Ltd. stock have upside surprise potential - mfd.ru
Will CollPlant Biotechnologies Ltd. stock rally after Fed decisionsJuly 2025 Review & Daily Stock Momentum Reports - mfd.ru
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
When Will CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Turn A Profit? - Yahoo Finance
CollPlant stock rating downgraded to Hold from Buy by D. Boral Capital - Investing.com Australia
CollPlant Biotechnologies Raises $2 Million in Registered Direct Offering with Concurrent Warrant Placement - TipRanks
This Impinj Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Friday - Benzinga
CollPlant (CLGN) to raise about $2.0M via direct share sale and warrants - Stock Titan
CollPlant to sell 1.6M ordinary shares at $1.25 in registered direct offering - Yahoo Finance
United States shares lower at close of trade; Dow Jones Industrial Average down 1.20% By Investing.com - Investing.com India
U.S. shares lower at close of trade; Dow Jones Industrial Average down 1.20% - Investing.com UK
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.20% - Investing.com
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
CollPlant (CLGN) Announces Stock Offering and Private Placement - GuruFocus
CollPlant raises $2M, sells 1.6M shares and issues warrants - Stock Titan
Does CollPlant Biotechnologies Ltd. stock have upside surprise potentialTrade Signal Summary & Daily Entry Point Trade Alerts - mfd.ru
Is CollPlant Biotechnologies Ltd. stock oversold or undervaluedCup and Handle Formations & Connect With Bulls, Avoid the Bears - Bollywood Helpline
Surprises Report: Can CollPlant Biotechnologies Ltd sustain earnings growthRisk Management & Target Return Focused Stock Picks - baoquankhu1.vn
CollPlant Biotechnologies Up 14%, But Some Insiders Miss Out - simplywall.st
Momentum Shift: What technical signals suggest for CollPlant Biotechnologies Ltd stockJuly 2025 Fed Impact & Capital Protection Trade Alerts - Bộ Nội Vụ
Aug Selloffs: Will Unisys Corporation stock go up in YEAR2025 Fundamental Recap & Risk Controlled Daily Plans - baoquankhu1.vn
Collplant Biotechnologies Ltd (CLGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):